ArticleThe Pan African medical journal2026
Renal survival in hereditary urolithiasis: a monocentric cohort study from a Tunisian nephrology department.
Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: hereditary urolithiasis (HUL) is rare and often underdiagnosed. The genetic type contributes, with other factors, to the onset of renal failure and its progression to end-stage renal disease (ESRD). The aim of our study was to determine the incidence of progression to ESRD and to identify factors influencing renal survival. Methods: we conducted an analytical retrospective study in our department of nephrology for 31 years [1990-2021]. Records of patients with HUL who were not in ESRD at diagnosis were retained. We performed a Cox proportional hazards model. Results: we included 73 patients, of whom 60.3% (n=44) were males. The mean age at the onset of urolithiasis symptomatology was 19.15± 15.57 years. The causes were cystinuria, hereditary tubulopathies and primary hyperoxaluria (PH), in 31, 24 and 18 cases, respectively. The delay in the etiological diagnosis was over 5 years in 41.1% (n=30). After a follow-up of an average period of 16 years, the annual incidence of ESRD was 0.94% and the annual decline in glomerular filtration rate was 3.5 ml/min. The multivariate study retained only PH as an independent factor associated with the occurrence of ESRD with an adjusted hazard ratio of 10.52, 95% CI: 1.664-66.507; p= 0.012. Primary hyperoxaluria had the highest annual incidence of ESRD during follow-up (3.42% vs. 0.46% for tubulopathies). The annual decline in glomerular filtration rate in PH was 5.73 ml/min, vs 2.9 ml/min in cystinuria and 2.67 ml/min in tubulopathies. Conclusion: primary hyperoxaluria was the main determinant of ESRD, highlighting the need for early etiological and genetic diagnosis, especially in consanguineous populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.